Christopher E. Nelson
Assistant Professor, The Twenty-First Century Professorship in Biomedical Engineering
Our lab develops biologically inspired strategies for controlled drug and gene delivery for gene therapy and regenerative medicine.
Delivery of genome editing technologies – As therapeutics, genome editing technologies hold great promise. The challenge is safe and efficient delivery to diseased tissues in the patient. We are adapting viral and non-viral delivery vehicles and assessing safety and efficiency in preclinical models of disease.
Gene regulation in regenerative medicine and wound healing – Changes to gene expression in chronic disease delaying or preventing tissue regeneration or restoration. Targeted control of gene expression can illuminate new drug targets.
- Postdoctoral Fellow, Duke University
- Ph.D., Vanderbilt University
- B.S., University of Arkansas
- Controlled Release Society Postdoctoral Fellowship
- The Hartwell Foundation Postdoctoral Fellowship
- Pathway to Independence Award - K99/R00 (NIH/NIBIB)